1.Quality Evaluation of Domestic Pharmacoeconomic Literatures Based on PEERs in Recent Years
Hailiang GAO ; Tingting JIANG ; Cong ZHANG ; Mengpei ZHANG ; Haoxiang ZHANG ; Zhiheng WANG ; Lizhong DUAN ; Wentao ZHU
China Pharmacy 2019;30(10):1393-1395
OBJECTIVE: To investigate current status and quality of domestic pharmacoeconomic literatures, and to provide reference for the standardization of pharmacoeconomic research. METHODS: Retrieved from CNKI, Wanfang, VIP and other database, the pharmacoeconomic literatures published from Jan. 2017 to May 2018 were collected. The qualities of literatures were evaluated with Guidelines for Quality Evaluation of Pharmacoeconomics Evaluation Reports (“PEERs” for short). RESULTS: Totally 160 domestic pharmacoeconomic research literatures were included. The results of PEERs evaluation showed of which the coincidence rate was 32.5% (52/160). The literatureswhich were in full compliance (the report had a certain reference value) accounted for 1.3% (2/160), which were in basic compliance (the report had certain reference value after being revised) accounted for 31.3%(50/160),which were in non-conformity (the report did not had reference value) accounted for 67.5%(108/160). Domestic pharmacoeconomic researches were of high quality in terms of research object, evaluation method and content,research purpose, research design and design type, etc.; but the researches were of low quality in terms of research angle, incremental cost/incremental output analysis, sensitivity analysis and other aspects, and there was no explanation or unclear elaboration. CONCLUSIONS: The quality of domestic pharmacoeconomic research literatures are uneven, and their research quality needs to be further improved. It is recommended to standardize the evaluation of pharmacoeconomics, making the evaluation of pharmacoeconomics more scientific and objective.
2.Exploring effective components and therapeutic mechanism of Chaihu-Guizhi-Ganjiang decoction in treatment of chronic non-atrophic gastritis by UHPLC-Q-TOF/MS combined with network pharmacology
Tao WEN ; Guangyang JIAO ; Mengpei ZHAO ; Xiaoqiang YUE ; Feng ZHANG ; Wansheng CHEN
Journal of Pharmaceutical Practice and Service 2025;43(9):455-462
Objective To investigate the effective components and therapeutic mechanism of Chaihu-Guizhi-Ganjiang decoction in treating chronic non-atrophic gastritis. Methods The primary and secondary ion fragments of chemical components of Chaihu-Guizhi-Ganjiang decoction were obtained by UHPLC-Q-TOF/MS. Comparing with reference standards and literature information, a comprehensive characterization of the chemical constituents of Chaihu-Guizhi-Ganjiang decoction was conducted. Then, the network pharmacology approach was applied to explore the therapeutic mechanism of Chaihu-Guizhi-Ganjiang decoction in treatment of chronic non-atrophic gastritis based on the components in plasma and verified by immunohistochemical results. Results A total of 24 absorbed components of Chaihu-Guizhi-Ganjiang decoction were characterized, including 11 flavonoid glycosides, 3 fatty acids, 3organic acids, 2 gingerols, 2 flavonoids and, 1 each of fatty aldehydes, triterpenoids and amino acids, which mainly acted on TNF-α, IL-6, STAT3, and PTGS2. It exerted therapeutic effects by modulating signaling pathways, including the IL-17 signaling pathway and the AGE-RAGE signaling pathway, etc. Conclusion This study provided the first exploration of the effective components and therapeutic mechanism of Chaihu-Guizhi-Ganjiang decoction in treatment of chronic non-atrophic gastritis by UHPLC-Q-TOF/MS, which could offer scientific references for its further research.